{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T09:13:16Z","timestamp":1783501996203,"version":"3.55.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32200778"],"award-info":[{"award-number":["32200778"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32471504"],"award-info":[{"award-number":["32471504"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32471014"],"award-info":[{"award-number":["32471014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["5230130320"],"award-info":[{"award-number":["5230130320"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32101026"],"award-info":[{"award-number":["32101026"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ24H090001"],"award-info":[{"award-number":["LQ24H090001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["25KJA310003"],"award-info":[{"award-number":["25KJA310003"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008048","name":"Nanjing University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["2023SHZDZX02"],"award-info":[{"award-number":["2023SHZDZX02"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["ND2022A03"],"award-info":[{"award-number":["ND2022A03"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["SKY2022159"],"award-info":[{"award-number":["SKY2022159"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014358","name":"Second Affiliated Hospital of Soochow University","doi-asserted-by":"publisher","award":["ND2022A04"],"award-info":[{"award-number":["ND2022A04"]}],"id":[{"id":"10.13039\/501100014358","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ebiom.2026.106325","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:34:06Z","timestamp":1781008446000},"page":"106325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The complement C3-microglial axis in depression of Parkinson's disease: from mechanism to therapeutic intervention"],"prefix":"10.1016","volume":"129","author":[{"given":"Qiao","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jili","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozhe","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enyou","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linna","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8326-7779","authenticated-orcid":false,"given":"Li-Fang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4446-7222","authenticated-orcid":false,"given":"Qifei","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ebiom.2026.106325_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/brx2.70032","article-title":"Non-human primate models of Parkinson's disease: decoding pathogenesis and advancing therapies","volume":"3","author":"Zhang","year":"2025","journal-title":"Brain-X"},{"issue":"10423","key":"10.1016\/j.ebiom.2026.106325_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson's disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.ebiom.2026.106325_bib3","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1212\/WNL.0000000000001684","article-title":"Depression and subsequent risk of Parkinson disease","volume":"84","author":"Gustafsson","year":"2015","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106325_bib4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nrneurol.2015.126","article-title":"Depression\u2014risk factor or early symptom in Parkinson disease?","volume":"11","author":"Leentjens","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrneurol.2011.189","article-title":"Depression in Parkinson disease--epidemiology, mechanisms and management","volume":"8","author":"Aarsland","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ebiom.2026.106325_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.parkreldis.2016.12.026","article-title":"Gender differences in Parkinson's disease depression","volume":"36","author":"Perrin","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ebiom.2026.106325_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104749","article-title":"Prevalence and clinical aspects of depression in Parkinson's disease: a systematic review and meta-analysis of 129 studies","volume":"141","author":"Cong","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106325_bib8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s40266-022-00942-1","article-title":"Depression in patients with Parkinson's disease: current understanding of its neurobiology and implications for treatment","volume":"39","author":"Prange","year":"2022","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41531-023-00551-8","article-title":"Depressive symptoms in Parkinson's disease are insufficiently but more often treated than in other chronic conditions","volume":"9","author":"Usnich","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106325_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrneurol.2012.96","article-title":"Scales to detect depression in Parkinson disease","volume":"8","author":"Schrag","year":"2012","journal-title":"Nat Rev Neurol"},{"issue":"13","key":"10.1016\/j.ebiom.2026.106325_bib11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1212\/WNL.0b013e31824d587f","article-title":"A comparison of nine scales to detect depression in Parkinson disease: which scale to use?","volume":"78","author":"Williams","year":"2012","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106325_bib12","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s10571-019-00700-9","article-title":"Proteomics in Human Parkinson's disease: present scenario and future directions","volume":"39","author":"Dixit","year":"2019","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib13","doi-asserted-by":"crossref","first-page":"6430","DOI":"10.1038\/s41467-024-50718-x","article-title":"Proteogenomic network analysis reveals dysregulated mechanisms and potential mediators in Parkinson's disease","volume":"15","author":"Doostparast Torshizi","year":"2024","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106325_bib14","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1002\/brx2.66","article-title":"The L1CAM-positive extracellular vesicle-based biomarker as a promising predictor of Parkinson's disease","volume":"2","author":"Lai","year":"2024","journal-title":"Brain-X"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12920-016-0164-y","article-title":"Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease","volume":"9","author":"Dumitriu","year":"2016","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.ebiom.2026.106325_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2025.107851","article-title":"Plasma proteomic profiling reveals Parkinson's disease-associated proteins: a UK Biobank study","volume":"135","author":"Jiao","year":"2025","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ebiom.2026.106325_bib17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fnmol.2020.00080","article-title":"Integrated metabolomics and proteomics analysis reveals plasma lipid metabolic disturbance in patients with Parkinson's disease","volume":"13","author":"Hu","year":"2020","journal-title":"Front Mol Neurosci"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106325_bib18","first-page":"2833","article-title":"Proteomics and bioinformatics approaches for the identification of plasma biomarkers to detect Parkinson's disease","volume":"18","author":"Dong","year":"2019","journal-title":"Exp Ther Med"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106325_bib19","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s43587-025-00818-0","article-title":"Large-scale proteomic analyses of incident Parkinson's disease reveal new pathophysiological insights and potential biomarkers","volume":"5","author":"Gan","year":"2025","journal-title":"Nat Aging"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41531-023-00461-9","article-title":"A proteogenomic view of Parkinson's disease causality and heterogeneity","volume":"9","author":"Kaiser","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-023-00374-w","article-title":"Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson's disease","volume":"12","author":"Paslawski","year":"2023","journal-title":"Transl Neurodegener"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106325_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11910-013-0409-5","article-title":"Depression and Parkinson's disease: current knowledge","volume":"13","author":"Marsh","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"23","key":"10.1016\/j.ebiom.2026.106325_bib23","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1212\/01.wnl.0000313835.33830.80","article-title":"Determinants of disability and quality of life in mild to moderate Parkinson disease","volume":"70","author":"Muslimovic","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106325_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/08919887221119974","article-title":"Psychological factors associated with fear of falling avoidance behavior in Parkinson's disease: the role of depression, anxiety, and catastrophizing","volume":"36","author":"Rider","year":"2023","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41398-024-03070-z","article-title":"Shared and distinct cortical morphometric alterations in five neuropsychiatric symptoms of Parkinson's disease","volume":"14","author":"Lu","year":"2024","journal-title":"Transl Psychiatry"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106325_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14582","article-title":"Alterations in cortical volume and complexity in Parkinson's disease with depression","volume":"30","author":"Yuan","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.ebiom.2026.106325_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.957997","article-title":"Abnormal cortical atrophy and functional connectivity are associated with depression in Parkinson's disease","volume":"14","author":"Yin","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.ebiom.2026.106325_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2022.03.032","article-title":"Altered functional connectivity of ventral striatum subregions in De-novo Parkinson's disease with depression","volume":"491","author":"Wang","year":"2022","journal-title":"Neuroscience"},{"issue":"7918","key":"10.1016\/j.ebiom.2026.106325_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04806-x","article-title":"Targeting thalamic circuits rescues motor and mood deficits in PD mice","volume":"607","author":"Zhang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2026.106325_bib30","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1038\/s41401-025-01570-2","article-title":"Dysfunction of subthalamic dopaminergic circuitry contributes to anxiety- and depression-like behaviors in 6-OHDA lesion-induced hemiparkinsonian mice","volume":"46","author":"Zhang","year":"2025","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106325_bib31","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/sj.npp.1300914","article-title":"The serotonergic hypothesis for depression in Parkinson's disease: an experimental approach","volume":"31","author":"Leentjens","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106325_bib32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.mp.4000849","article-title":"Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease","volume":"6","author":"M\u00f6ssner","year":"2001","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.ebiom.2026.106325_bib33","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s12264-024-01323-x","article-title":"Alpha-synuclein fibrils inhibit activation of the BDNF\/ERK signaling loop in the mPFC to induce Parkinson's disease-like alterations with depression","volume":"41","author":"Ma","year":"2025","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.ebiom.2026.106325_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2024.103641","article-title":"GABAergic imbalance in Parkinson's disease-related depression determined with MEGA-PRESS","volume":"43","author":"Liu","year":"2024","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.ebiom.2026.106325_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.574776","article-title":"Parkinson's disease with depression: the correlations between neuroinflammatory factors and neurotransmitters in cerebrospinal fluid","volume":"12","author":"Lian","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.ebiom.2026.106325_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104844","article-title":"Dopamine D(4) receptors in the lateral habenula regulate depression-related behaviors via a pre-synaptic mechanism in experimental Parkinson's disease","volume":"140","author":"Hui","year":"2020","journal-title":"Neurochem Int"},{"key":"10.1016\/j.ebiom.2026.106325_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2023.173677","article-title":"Hydrogen sulfide attenuates depression-like behaviours in Parkinson's disease model rats by improving synaptic plasticity in a hippocampal Warburg effect-dependent manner","volume":"234","author":"Liu","year":"2024","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.ebiom.2026.106325_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2024.134559","article-title":"VGluT2 neuron subtypes in the paraventricular thalamic nucleus regulate depression in paraquat-induced Parkinson's disease","volume":"472","author":"Zhang","year":"2024","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.ebiom.2026.106325_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2024.111001","article-title":"Study on the mechanism of gut microbiota in the pathogenetic interaction between depression and Parkinson 's disease","volume":"215","author":"Zhang","year":"2024","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.ebiom.2026.106325_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148320","article-title":"Acupuncture inhibits autophagy and repairs synapses by activating the mTOR pathway in Parkinson's disease depression model rats","volume":"1808","author":"Ning","year":"2023","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106325_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/brx2.70031","article-title":"Licochalcone A selectively modulates mTORC1-TFEB to enhance autophagy and demonstrates neuroprotective effects in a mouse model of Parkinson's disease","volume":"3","author":"Wang","year":"2025","journal-title":"Brain-X"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib42","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/brainsci14010100","article-title":"Exploring Parkinson's disease-associated depression: role of inflammation on the noradrenergic and serotonergic pathways","volume":"14","author":"Sampaio","year":"2024","journal-title":"Brain Sci"},{"key":"10.1016\/j.ebiom.2026.106325_bib43","article-title":"Immune system disruptions implicated in whole blood epigenome-wide association study of depression among Parkinson's disease patients","volume":"26","author":"Paul","year":"2022","journal-title":"Brain Behav Immun Health"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106325_bib44","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1007\/s10072-022-06363-7","article-title":"Inflammatory markers and depression in Parkinson's disease: a systematic review","volume":"43","author":"Ramanzini","year":"2022","journal-title":"Neurol Sci"},{"key":"10.1016\/j.ebiom.2026.106325_bib45","article-title":"LPS activates neuroinflammatory pathways to induce depression in Parkinson's disease-like condition","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ebiom.2026.106325_bib46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson's disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl Neurodegener"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2047-9158-2-21","article-title":"What does complement do in Alzheimer's disease? Old molecules with new insights","volume":"2","author":"Shen","year":"2013","journal-title":"Transl Neurodegener"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106325_bib48","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41582-020-0400-0","article-title":"Complement in neurological disorders and emerging complement-targeted therapeutics","volume":"16","author":"Dalakas","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106325_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094675","article-title":"Aberrant complement system activation in neurological disorders","volume":"22","author":"Ziabska","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106325_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/biom12020337","article-title":"The complement system in the central nervous system: from neurodevelopment to neurodegeneration","volume":"12","author":"Chen","year":"2022","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106325_bib51","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s12264-021-00750-4","article-title":"Complement C3 aggravates post-epileptic neuronal injury via activation of TRPV1","volume":"37","author":"Jiang","year":"2021","journal-title":"Neurosci Bull"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106325_bib52","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1021\/acs.jproteome.0c01002","article-title":"Complement and coagulation cascades are potentially involved in dopaminergic neurodegeneration in \u03b1-Synuclein-Based mouse models of Parkinson's disease","volume":"20","author":"Ma","year":"2021","journal-title":"J Proteome Res"},{"issue":"15","key":"10.1016\/j.ebiom.2026.106325_bib53","article-title":"Botulinum neurotoxin induces neurotoxic microglia mediated by exogenous inflammatory responses","volume":"11","author":"Ambrin","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"5773","key":"10.1016\/j.ebiom.2026.106325_bib54","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106325_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42350","article-title":"Pioneering pain management with botulinum toxin type A: from anti-inflammation to regenerative therapies","volume":"11","author":"Rahmatipour","year":"2025","journal-title":"Heliyon"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106325_bib56","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/1357-4310(96)84845-3","article-title":"Botulinum neurotoxins: mechanism of action and therapeutic applications","volume":"2","author":"Montecucco","year":"1996","journal-title":"Mol Med Today"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106325_bib57","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0968-0004(02)02177-1","article-title":"Botulinum and tetanus neurotoxins: structure, function and therapeutic utility","volume":"27","author":"Turton","year":"2002","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106325_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/toxins14060383","article-title":"Treatment of depression with botulinum toxin","volume":"14","author":"Wollmer","year":"2022","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.ebiom.2026.106325_bib59","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/164_2019_272","article-title":"The use of botulinum toxin for treatment of depression","volume":"263","author":"Wollmer","year":"2021","journal-title":"Handb Exp Pharmacol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106325_bib60","first-page":"2717","article-title":"Effects of botulinum toxin type a on mood and cognitive function in patients with Parkinson'S disease and depression","volume":"13","author":"Zhu","year":"2021","journal-title":"Am J Transl Res"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106325_bib61","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/08919887241281066","article-title":"Treatment of neuropsychiatric symptoms in Parkinson's disease with botulinum toxin A: a 12 week randomized, double-blind, placebo-controlled trial","volume":"38","author":"Zhu","year":"2025","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106325_bib62","first-page":"745","article-title":"Clinical study on the efficacy and safety of botulinum toxin A in the treatment of Parkinson\u2019 s disease with depression","volume":"52","author":"Lyu","year":"2019","journal-title":"Chin J Neurol"},{"key":"10.1016\/j.ebiom.2026.106325_bib63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.toxicon.2019.12.153","article-title":"Botulinum toxin type A ameliorates adjuvant-arthritis pain by inhibiting microglial activation-mediated neuroinflammation and intracellular molecular signaling","volume":"178","author":"Shi","year":"2020","journal-title":"Toxicon"},{"issue":"38","key":"10.1016\/j.ebiom.2026.106325_bib64","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.2174\/0113816128318908240730093036","article-title":"Exploring the biomarkers and potential mechanisms of botulinum toxin type A in the treatment of microglial inflammatory activation through P2X7 receptors based on transcriptome sequencing","volume":"30","author":"Zhang","year":"2024","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ebiom.2026.106325_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2024.108182","article-title":"Botulinum toxin A dampened inflammatory response in BV-2 microglial cells","volume":"252","author":"Filho","year":"2024","journal-title":"Toxicon"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106325_bib66","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s12264-019-00367-8","article-title":"Antidepressant-like action of single facial injection of botulinum neurotoxin A is associated with augmented 5-HT levels and BDNF\/ERK\/CREB pathways in mouse brain","volume":"35","author":"Li","year":"2019","journal-title":"Neurosci Bull"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib67","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41420-021-00676-w","article-title":"Phosphorylated \u03b1-synuclein aggregated in Schwann cells exacerbates peripheral neuroinflammation and nerve dysfunction in Parkinson's disease through TLR2\/NF-\u03baB pathway","volume":"7","author":"Sun","year":"2021","journal-title":"Cell Death Discov"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106325_bib68","first-page":"1322","article-title":"Botulinum neurotoxin A ameliorates depressive-like behavior in a reserpine-induced Parkinson's disease mouse model via suppressing hippocampal microglial engulfment and neuroinflammation","volume":"44","author":"Li","year":"2023","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib69","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1038\/s41467-018-04569-y","article-title":"TLR9 activation via microglial glucocorticoid receptors contributes to degeneration of midbrain dopamine neurons","volume":"9","author":"Maatouk","year":"2018","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106325_bib70","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/s41596-018-0011-z","article-title":"Sucrose preference test for measurement of stress-induced anhedonia in mice","volume":"13","author":"Liu","year":"2018","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ebiom.2026.106325_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/inmd.70118","article-title":"Complement C3 mediates adolescent social isolation-induced hippocampal synaptic deficits and sex-specific emotional dysfunction","author":"Qi","year":"2026","journal-title":"Interdiscip Med"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106325_bib72","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/s41593-025-01979-2","article-title":"GABA-dependent microglial elimination of inhibitory synapses underlies neuronal hyperexcitability in epilepsy","volume":"28","author":"Chen","year":"2025","journal-title":"Nat Neurosci"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106325_bib73","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41593-020-0672-0","article-title":"The endogenous neuronal complement inhibitor SRPX2 protects against complement-mediated synapse elimination during development","volume":"23","author":"Cong","year":"2020","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib74","first-page":"9","article-title":"Application of single-cell sequencing technology and its clinical implications in Parkinson's disease and Alzheimer's disease: a narrative review","volume":"2","author":"Chen","year":"2025","journal-title":"Adv Technol Neurosci"},{"key":"10.1016\/j.ebiom.2026.106325_bib75","series-title":"GeneReviews(\u00ae). Seattle (WA): University of Washington, Seattle. Copyright \u00a9 1993-2025, University of Washington, Seattle","article-title":"PTS-related tetrahydrobiopterin deficiency (PTPSD)","author":"Opladen","year":"1993"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib76","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuron.2014.11.018","article-title":"NF\u03baB-Activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer's Disease","volume":"85","author":"Lian","year":"2015","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106325_bib77","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.neuron.2018.10.031","article-title":"Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer\u2019s Disease","volume":"100","author":"Litvinchuk","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.ebiom.2026.106325_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2023.111821","article-title":"Sex and gender differences in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis: a narrative review","volume":"212","author":"Nicoletti","year":"2023","journal-title":"Mech Ageing Dev"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106325_bib79","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000445751","article-title":"The incidence of Parkinson's disease: a systematic review and meta-analysis","volume":"46","author":"Hirsch","year":"2016","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106325_bib80","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ncl.2022.12.001","article-title":"Sex and gender differences in Parkinson's disease","volume":"41","author":"Patel","year":"2023","journal-title":"Neurol Clin"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib81","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1038\/s41467-024-48961-3","article-title":"Plasma proteomics identify biomarkers predicting Parkinson's disease up to 7 years before symptom onset","volume":"15","author":"H\u00e4llqvist","year":"2024","journal-title":"Nature Communications"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106325_bib82","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1038\/s41591-025-03833-1","article-title":"Shared and disease-specific pathways in frontotemporal dementia and Alzheimer's and Parkinson's diseases","volume":"31","author":"Ali","year":"2025","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106325_bib83","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1038\/s41591-025-03834-0","article-title":"The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging","volume":"31","author":"Imam","year":"2025","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib84","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s43856-023-00294-w","article-title":"Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson's disease","volume":"3","author":"Hadisurya","year":"2023","journal-title":"Commun Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib85","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00401-024-02706-0","article-title":"Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson's disease","volume":"147","author":"Rutledge","year":"2024","journal-title":"Acta Neuropathol"},{"issue":"14","key":"10.1016\/j.ebiom.2026.106325_bib86","doi-asserted-by":"crossref","first-page":"e1434","DOI":"10.1212\/WNL.0000000000207725","article-title":"High-throughput CSF proteomics and machine learning to identify proteomic signatures for parkinson disease development and progression","volume":"101","author":"Tsukita","year":"2023","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib87","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41531-024-00645-x","article-title":"Large-scale proteomics analysis of five brain regions from Parkinson's disease patients with a GBA1 mutation","volume":"10","author":"Blumenreich","year":"2024","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib88","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69480-3","article-title":"A glycomics and proteomics study of aging and Parkinson's disease in human brain","volume":"10","author":"Raghunathan","year":"2020","journal-title":"Sci Rep"},{"issue":"771","key":"10.1016\/j.ebiom.2026.106325_bib89","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo1997","article-title":"Single-cell transcriptomic and proteomic analysis of Parkinson's disease brains","volume":"16","author":"Zhu","year":"2024","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106325_bib90","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s43587-022-00194-z","article-title":"Suppression of intestinal dysfunction in a Drosophila model of Parkinson's disease is neuroprotective","volume":"2","author":"Fedele","year":"2022","journal-title":"Nat Aging"},{"key":"10.1016\/j.ebiom.2026.106325_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101514","article-title":"Identification of blood-based biomarkers for diagnosis and prognosis of Parkinson's disease: a systematic review of proteomics studies","volume":"73","author":"Chelliah","year":"2022","journal-title":"Ageing Res Rev"},{"issue":"Suppl 1(0,1)","key":"10.1016\/j.ebiom.2026.106325_bib92","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S1353-8020(13)70025-7","article-title":"Blood-based biomarkers for Parkinson's disease","volume":"20","author":"Chahine","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ebiom.2026.106325_bib93","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbi.2024.09.022","article-title":"Astrocyte-neuron communication through the complement C3-C3aR pathway in Parkinson's disease","volume":"123","author":"Chi","year":"2025","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.ebiom.2026.106325_bib94","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bbi.2021.04.003","article-title":"Astrocytic Kir6.1 deletion aggravates neurodegeneration in the lipopolysaccharide-induced mouse model of Parkinson's disease via astrocyte-neuron cross talk through complement C3-C3R signaling","volume":"95","author":"Chen","year":"2021","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib95","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41531-025-01005-z","article-title":"Complement C4 exacerbates astrocyte-mediated neuroinflammation and promotes \u03b1-synuclein pathology in Parkinson's disease","volume":"11","author":"Zou","year":"2025","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.ebiom.2026.106325_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103369","article-title":"Microglial CR3 promotes neuron ferroptosis via NOX2-mediated iron deposition in rotenone-induced experimental models of Parkinson's disease","volume":"77","author":"Wang","year":"2024","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib97","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12974-024-03234-0","article-title":"Exercise training upregulates CD55 to suppress complement-mediated synaptic phagocytosis in Parkinson's disease","volume":"21","author":"Yao","year":"2024","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.ebiom.2026.106325_bib98","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40035-018-0113-0","article-title":"Treating refractory depression in Parkinson's disease: a meta-analysis of transcranial magnetic stimulation","volume":"7","author":"Lesenskyj","year":"2018","journal-title":"Transl Neurodegener"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106325_bib99","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/1570159X17666191016094857","article-title":"Drug choices and advancements for managing depression in Parkinson's disease","volume":"18","author":"Assogna","year":"2020","journal-title":"Curr Neuropharmacol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106325_bib100","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40261-024-01378-8","article-title":"Selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis","volume":"44","author":"Gao","year":"2024","journal-title":"Clin Drug Investig"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib101","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/toxins13010042","article-title":"Botulinum toxin in movement disorders: an update","volume":"13","author":"Anandan","year":"2021","journal-title":"Toxins"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106325_bib102","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3390\/toxins13110751","article-title":"Botulinum neurotoxins in central nervous system: an overview from animal models to human therapy","volume":"13","author":"Luvisetto","year":"2021","journal-title":"Toxins"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106325_bib103","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3390\/brainsci14070631","article-title":"Improving spasticity by using botulin toxin: an overview focusing on combined approaches","volume":"14","author":"Raciti","year":"2024","journal-title":"Brain Sci"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106325_bib104","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/toxins9090260","article-title":"Botulinum toxin for the treatment of neuropathic pain","volume":"9","author":"Park","year":"2017","journal-title":"Toxins"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106325_bib105","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/toxins13030226","article-title":"Therapeutic applications of botulinum neurotoxin for autonomic symptoms in Parkinson's disease: an updated review","volume":"13","author":"Mitchell","year":"2021","journal-title":"Toxins"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106325_bib106","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/toxins16020096","article-title":"From toxin to treatment: a narrative review on the use of botulinum toxin for autonomic dysfunction","volume":"16","author":"Rempel","year":"2024","journal-title":"Toxins"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106325_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/toxins15050336","article-title":"Botulinum toxin treatment for depression: a new paradigm for psychiatry","volume":"15","author":"Finzi","year":"2023","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.ebiom.2026.106325_bib108","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jad.2022.08.097","article-title":"Botulinum toxin A (BoNT\/A) for the treatment of depression: a randomized, double-blind, placebo, controlled trial in China","volume":"318","author":"Li","year":"2022","journal-title":"J Affect Disord"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106325_bib109","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2333","article-title":"The safety and efficacy of botulinum toxin A on the treatment of depression","volume":"11","author":"Zhang","year":"2021","journal-title":"Brain Behav"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106325_bib110","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.celrep.2016.06.104","article-title":"Interneuronal transfer and distal action of tetanus toxin and botulinum neurotoxins A and D in central neurons","volume":"16","author":"Bomba-Warczak","year":"2016","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106325_bib111","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13578-023-00964-1","article-title":"Neurocircuitry underlying the antidepressant effect of retrograde facial botulinum toxin in mice","volume":"13","author":"Ni","year":"2023","journal-title":"Cell Biosci"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:14:11Z","timestamp":1783498451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426002070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":111,"alternative-id":["S2352396426002070"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106325","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The complement C3-microglial axis in depression of Parkinson's disease: from mechanism to therapeutic intervention","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106325"}}